Pegon, Ashlee Jane .

HRN: 25-89-25  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/22/2026
CO-AMOXICLAV 625MG (TAB)
01/22/2026
01/28/2026
PO
625mg
BID
Urinary Tract Infection
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: